Pharming Group N.V. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Leiden, Netherlands
SEC filing record 1 source field available
Fiscal year end
31 December
Pharming Group N.V. has filed 147 SEC EDGAR filings since 14 Oct 2020

SEC filing history

Showing 26-50 of 147 matching filings.

Per page
25
Current page
2
6-K File 001-39822

6-K

Filing date
06 Oct 2025
Reporting date
06 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
01 Oct 2025
Reporting date
01 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
10 Sep 2025
Reporting date
10 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
02 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
31 Jul 2025
Reporting date
31 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
24 Jun 2025
Reporting date
24 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
11 Jun 2025
Reporting date
11 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
08 May 2025
Reporting date
08 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
30 Apr 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
25 Apr 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
23 Apr 2025
Reporting date
23 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94404

SCHEDULE 13G/A filing

Filing date
07 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
03 Apr 2025
Reporting date
03 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
20 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
13 Mar 2025
Reporting date
13 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
04 Mar 2025
Reporting date
04 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
20 Feb 2025
Reporting date
20 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
07 Feb 2025
Reporting date
07 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
21 Jan 2025
Reporting date
21 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
21 Jan 2025
Reporting date
21 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
16 Dec 2024
Reporting date
15 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39822

6-K

Filing date
11 Dec 2024
Reporting date
11 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94404

PHARMING GROUP N.V.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94404

MS INITIAL

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .